Hikma Pharmaceuticals Plc

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Hikma Pharmaceuticals Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.84% vs 5.81% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.00% vs 83.37% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,541.20",
          "val2": "2,447.20",
          "chgp": "3.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "591.90",
          "val2": "629.20",
          "chgp": "-5.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "77.40",
          "val2": "68.90",
          "chgp": "12.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "33.40",
          "val2": "-39.10",
          "chgp": "185.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "308.80",
          "val2": "283.30",
          "chgp": "9.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "169.60%",
          "val2": "194.10%",
          "chgp": "-2.45%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,541.20

2,447.20

3.84%

Operating Profit (PBDIT) excl Other Income

591.90

629.20

-5.93%

Interest

77.40

68.90

12.34%

Exceptional Items

33.40

-39.10

185.42%

Consolidate Net Profit

308.80

283.30

9.00%

Operating Profit Margin (Excl OI)

169.60%

194.10%

-2.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.84% vs 5.81% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 9.00% vs 83.37% in Dec 2024

All Annual Results